Effects of curcumin on ECV304 cell's proliferation and expression of matrix metalloproteinase-2

Journal of China Pharmaceutical University

Volumn 37, Issue 3, 2006, Pages 268-272

  Xiao, Jian ^a,c   Li, Xiao Kun ^a   Chen, Lin Hua ^b   Yao, Chong Shun ^a   Wu, Zhi Ling ^c   Li, Wen Jun ^c  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Curcumin; ECV304; Inhibition; Metalloproteinase 2

Indexed keywords

CURCUMIN; GELATINASE A; MESSENGER RNA; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GIEMSA STAIN; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOSIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; ZYMOGRAPHY;

EID: 33745685499     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ruby AJ, Kutta G, Dinesh Babu K, et al. Anti-tumour and antioxidant activity of natural curcuminoids[J]. Cancer Lett, 1995, 94(4):79-83.
2. Mohan DE, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including exprission of matrix metalloproteinase gelatinase B[J]. J Biol Chem, 2000, 275(14): 10405-10412.
3. Johnso LI, Dyer R, Hupe DJ. Matrix metalloproteinase[J]. Cur Opin Chem Biol, 1998,2(4):466-471.
4. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications [J]. J Clin Oncol,2000,18(5):1135-1149.
5. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression[J]. Nat Rev Cancer,2002,7(12):161-174.
6. (Li JM), (Yang HP). Chinese source. (Chin J Clin Rehabil), 2004,8(27):5830-5832.
7. Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far [J]. Eur J Cancer,2005,41(9):1955-1968.
8. (Chen XF), (Gu ZL), (Liang ZQ). Chinese source. (Chin Pharmacol Bull), 2001,17(3):253-256.
9. Hofmann UB, Westphal JR, van Muijen GNP, et al. Matrix metalloproteinases in human melanoma[J]. J Invest Dermatol, 2000, 115 (3):337-344.
10. Mannello F, Tonti G, Papa S. Matrix metalloproteinase inhibitors as anticancer therapeutics[J]. Curr Cancer Drug Targets, 2005,5(4): 285-298.